The data in this review were from papers identified from PubMed searches using the terms, “post-kala-azar dermal leishmaniasis”, “post-kala-azar”, “dermal leishmaniasis”, “PKDL”, and “PKADL”. Additional data originated from papers in reference lists of reviewed articles and from the authors' personal archives. Reference were selected for their scientific contribution to various aspects of PKDL. Case reports were used for areas in which not other studies were available. English and French papers
ReviewPost-kala-azar dermal leishmaniasis
Section snippets
Clinical features
The clinical features have been best described in reports from Sudan and India and are summarised in table 1.
Epidemiology
PKDL occurs mainly in L donovani-endemic areas and most studies reported are from Asia (mainly India) and east Africa, mainly Kenya and Sudan (table 1).
Parasites
Several studies from Sudan showed that in cultures from bone marrow or lymph node aspirates from patients with VL analysed by isoenzyme electrophoresis, L donovani, L infantum, and Leishmania archibaldi, which takes an intermediate position in the cladogram, are seen.68, 69, 70 However, the three species were all seen to be L donovani sensulato by Southern blotting and fingerprinting and were clearly different from a L infantum reference strain,69 which supports association between VL and PKDL
Pathogenesis and immunology
The exact mechanisms underlying the development of PKDL still remain to be elucidated. There is accumulating evidence, however, that (developing) immune responses have a major role.
In VL a specific cell-mediated immune (CMI) response to the leishmania parasite is absent, and only develops after treatment. This can be measured in vitro in experiments in which peripheral blood mononuclear cells (PBMC) are stimulated or in vivo by the leishmanin skin test.
Early studies from India showed CMI
Pathology
Irrespective of the clinical forms the epidermis shows several changes in different combinations. These include hyperkeratosis, parakeratosis, focal acanthosis, or atrophy of the rete pegs, and liquifaction degeneration of the basal cells.88 The last is associated with focal infiltration of the basal layer by lymphocytes. Under electron microscopy the lymphocytes are in intimate contact with melanocytes and basal keratinocytes. The latter cells seem to be damaged by the infiltrating
Predictors of PKDL
No convincing clinical predictors have been identified that are helpful to predict who will develop PKDL and who will not. One Sudanese study showed spleen size at time of VL to be correlated with development of PKDL,85 but another study did not confirm this.2 In a further study from Sudan it was suggested that inadequate treatment regimens may be important.2 This possibility was also suggested from India where all patients presenting with PKDL had short duration of treatment for VL.3 It is
Diagnosis
In most endemic areas diagnosis will be made clinically by a history of previous VL, the temporal association with VL, the distribution and appearance of the lesions, by ruling out other disorders, and by the response to treatment. Parasitological confirmation may be sought if in doubt. Studies from India showed that smears are more likely to show amastigotes if taken from a larger lesion or from nodular (67–100%) lesions compared with papulard (36–69%) and macular lesions (7–33%).4, 96
Treatment
There are few controlled studies on the management of PKDL and most data come from small case series. In addition, there are differences in approach according to geographical area. An overview of studies available is given in table 2.
Conclusion
PKDL is now recognised as a frequent complication of VL in most endemic areas with important clinical and epidemiological implications. Although in the past decade studies have considerably increased our understanding of PKDL, many issues remain unresolved and should be the subject of further research (panel). These might include studies that increase our basic understanding in pathogenesis and management, but should also be focused on the public-health aspects of PKDL, especially in relation
Search strategy and selection criteria
References (125)
Leishmaniasis. Public health aspects and control
Clin Dermatol
(1996)- et al.
Post-kala-azar dermal leishmaniasis in the Sudan: clinical presentation and differential diagnosis
Br J Derm
(2000) - Musa AM, Khalil EAG, Raheem MA, et al. The natural history of Sudanese post- kala-azar dermal leishmaniasis: clinical,...
- et al.
Post-kala-azar dermal leishmaniasis
Int J Derm
(1995) - et al.
A clinical study of post-kala-azar dermal leishmaniasis
Indian Med Gaz
(1930) - et al.
Post-kala-azar dermal leishmaniasis
Br J Derm
(1977) A review of kala-azar in China from 1949 to 1959
Trans R Soc Trop Med Hyg
(1982)- et al.
Post-kala-azar dermal leishmaniasis in Nepal
Int J Derm
(2001) - et al.
Endemic kala-azar in eastern Sudan. Post-kala-azar dermal leishmaniasis
Am J Trop Med Hyg
(1995) - et al.
Efficacy of prolonged therapy with stibogluconate in post kala-azar dermal leishmaniasis
Indian J Med Res
(1990)
Post kala-azar dermal leishmaniasis in the Sudan: clinical features, pathology and treatment
Trans R Soc Trop Med Hyg
Visceral leishmaniasis associated with post-kala-azar dermal leishmaniasis
J Assoc Phys Ind
Kala-azar with disseminated dermal leishmaniasis
Am J Trop Med Hyg
Kala-azar chez l'immunodéprimé. A propos d'un cas révélé par des signes cutanés
Presse Med
Lymphadenopathy in Indian kala-azar and dermal leishmanoid
Indian J Pathol Bacteriol
Post-kala-azar anterior uveitis: demonstration of Leishmania parasites in the lesion
Trans R Soc Trop Med Hyg
Post-kala-azar ocular leishmaniasis
Trans R Soc Trop Med Hyg
Sudan mucosal leishmaniasis: epidemiology, clinical features, diagnosis, immune responses and treatment
Trans R Soc Trop Med Hyg
Leishmanial cholecystitis and colitis in a patient with visceral leishmaniasis
Trans R Soc Trop Med Hyg
Laryngeal involvement during post kala-azar dermal leishmaniaisis in India
Trop Med Int Health
Recurrence of kala-azar associated with post- kala-azar dermal leishmaniasis
J Indian Med Assoc
Recurrence of kala-azar after PKDL: role of co-factors
Trop Med Int Health
Epidemiology of visceral leishmaniasis in India
Nat Med J India
Post kala-azar dermal leishmaniasis: the Kenyan experience
East Afr Med J
Post-kala-azar dermal leishmaniasis occurring long after cure of visceral leishmaniasis in Kenya
East Afr Med J
Post kala-azar dermal leishmaniasis
Br J Derm
A new form of cutaneous leishmaniasis-dermal leishmanoid
Indian Med Gaz
Epidemiological, clinical and therapeutic features of Bihar kala-azar (including post kala-azar dermal leishmaniasis)
Trans R Soc Trop Med
Ten years of kala-azar in west Bengal, part 1. Did post kala azar dermal leishmaniasis initiate outbreak 24-Parganas?
Bull World Health Org
Screening sandflies for natural infection with Leishmania donovani, using a non-radioactive probe based on the total DNA of the parasite
Ann Trop Med Parasitol
Ecology and epidemiology: Old World
Earthquakes, influenza and cycles of Indian kala-azar
Trans R Soc Trop Med Hyg
Clinico-epidemiological profiles of post-kala-azar dermal leishmaniasis in Varanasi
J Com Dis
Reactivity of various leishmanial antigens in a direct agglutination test and their value in differentiating post-kala azar dermal leishmaniasis from leprosy and other skin conditions
J Med Microbiol
Information on the epidemiology and control of the leishmaniases by country or territory. WHO/Leish91.3
Studies on leishmaniasis in China. Historical background, epidemiology, clinical aspects, legislature and control program
Chin Med J
A review of kala-azar in China from 1949-1959
Trans R Soc Trop Med Hyg
Introduced leishmaniasis on Taiwan
Southeast Asian J Trop Med Pub Health
Autochthonous cutaneous-subcutaneous leishmaniasis on Taiwan
Am J Trop Med Hyg
Preliminary notes on dermal leishmaniasis in the Anglo-Egyptian Sudan
Trans R Soc Trop Med Hyg
Studies in leishmaniasis in the Anglo-Egyptian Sudan. IV. A punctate rash in treated cases
Trans R Soc Trop Med Hyg
Visceral leishmaniasis in the Sudan: clinical and hematological features
Ann Saudi Med
Kala-azar in displaced people from southern Sudan: epidemiological, clinical and therapeutic findings
Trans R Soc Trop Med Hyg
Post-kala-azar dermal leishmaniasis in the absence of active visceral leishmaniasis
Lancet
Epidemiology and clinical manifestations of L donovani infection in two villages in an endemic area in eastern Sudan
Trop Med Int Health
Post-kala-azar dermal leishmaniasis: does it play a role in the transmission of Leishmania donovani in the Sudan?
Trop Med Int Health
Identification of Leishmania donovani using a polymerase chain reaction in patient and animal material obtained from an area of endemic kala-azar in the Sudan
Acta Trop
Visceral leishmaniasis in Sudan: first identifications of Leishmania from dogs
Trans R Soc Trop Med Hyg
Ethiopian visceral leishmaniasis: generic and proprietary sodium stibogluconate are equivalent; HIV co-infected patients have a poor outcome
Trans R Soc Trop Med Hyg
East African kala-azar with special reference to the pathology, prophylaxis and treatment
Trans R Soc Trop Med Hyg
Cited by (441)
HIV and skin infections
2024, Clinics in DermatologyBarriers to the effective management and prevention of post kala-azar dermal leishmaniasis (PKDL) in the Indian subcontinent
2023, Medical Journal Armed Forces IndiaAn unusual paediatric case of post–kala-azar dermal leishmaniasis: a hidden parasite under the veil of white
2023, Clinical Microbiology and InfectionLeishmaniasis
2023, Manson's Tropical Diseases, Fourth EditionChallenges for maintaining post elimination phase of visceral leishmaniasis control programme in India: A field-based study
2024, PLoS Neglected Tropical Diseases